Tradestie Institutional Equity Comparison Engine

ABVC vs XFIX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVC Overall Edge

ABVC Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABVC BioPharma, Inc. Common Stock (ABVC) driven by superior Growth & Margin while XFIX counters with relative strength in Momentum & Technical. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus XFIX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XFIX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABVC N/M vs XFIX N/M Fwd P/E
Growth & Margin Winner ABVC
Op Margin 0.0% vs N/A ยท YoY +104.5% vs N/A
Momentum & Technical Winner XFIX
1Y -68.2% vs -1.1% ยท 52W Pos 7% vs 66%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ABVC NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
1M Return -17.28%
1Y Return -68.15%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
XFIX NASDAQ
F/m Opportunistic Income ETF
Institutional Equity
$51.96
-0.04% 1D
Market Cap N/A
1M Return -0.01%
1Y Return -1.15%
Forward P/E N/M
Unified AI Score
55.5 / 100 HOLD
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVC -68.15% XFIX -1.15% Spread: +21.69 pp (XFIX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVC TTM Op. Margin: 0.0% XFIX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs XFIX. Trailing 12-month operating profitability (ABVC 0.0% vs XFIX N/A) and valuation multiples (ABVC N/M vs XFIX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVC (5) vs XFIX (3)
Institutional Metric ABVC XFIX Criterion Row Winner
Market Capitalization Scale $23.9M N/A Larger Scale ABVC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +104.5% N/A Higher Growth ABVC
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin ABVC
Net Profit Margin Profitability 0.0% N/A Higher Margin ABVC
Return on Equity (ROE) Capital Efficiency -52.7% N/A Higher ROE ABVC
52-Week Range Position Momentum 7% ($1โ€“$3) 66% ($51โ€“$53) Stronger Trend XFIX
Beta / 30D Volatility Risk Regime 1.24ฮฒ ยท 44% Vol 0.06ฮฒ ยท 2% Vol Lower Realized Risk XFIX
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 55.5 / 100 (HOLD) Higher Composite XFIX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVC vs XFIX Buy Guide
ABVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XFIX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XFIX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVC nor XFIX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.